Minutes - Medication WG 2022-06-21

From Health Level 7 Belgium Wiki
Attendees
  • Annemieke Vergauwe
  • Bart Decuypere
  • Jean-Michel Polfliet
  • Jens Penny
  • José Costa Teixeira
  • Karlien Erauw
  • Pablo Christiaens
  • Tom Henkens
Excused/Not present
  • Anne Nerenhausen
  • Bruno Casneuf
  • Dieter Sauvillers
  • Elhassan Baazizi
  • Hanne Vuegen
  • Jan Lenie
  • Jean-Louis Maggetto
  • Katrien Thorré
  • Lars Vanreppelen
  • Marc Buckens
  • Nick Hermans
  • Nils Devos
  • Richard Francken
  • Thomas Van Langendonck
  • Tom De Backer
  • Walter Bollaert
  • Will van Norel
Agenda
  • Future of medication scheme
Minutes
  • Can we propose a publication of the medication scheme consisting of treatment lines
  • Business rules of RIZIV are pending
  • Examples are still missing
  • Advantage of publishing : reaching out to stakeholders (* although before we said that the business rules should be part of the implementation guide )
  • Medication treatments & medication treatment lines
  • Prescription system could start using the medication treatment
  • Medication statement : what is it ?
  • Medication prescription
  • Whenever you have a medication, you have a medication treatment
  • How do we call it : medication line, medication statement line, medication treatment line ?


  • however, can we go and publish the medication scheme ?
  • goal is for prescribor applications to start using the medication treatment
  • "The concept of "Medication Treatment Plan" of a patient represents the collection of all medication the patient was planned to take in the past, presently of in the future..."
  • and looking at scheme p16 at treatment plan
  • Looking at IHE Pharmacy supplement for treatment definition
  • We need to add a glossary on medication, José will start on it as google doc or github
  • we also need an aggregated diagram incl. reconciliation of doctors

Agenda items for next meeting

  • Current state of profiles on medication view and treatment lines and how it all works at operational level
  • Review glossary of terms &
  • Collect feedback on contraindications
  • Identifying business rules

Next meeting July 12 at 11AM